Delivery Order SPE2DB20D2014-SPE2DB25FC89F
- Not listed
- The Defense Logistics Agency awarded a $12,175.63 delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Risperdal 2 mg tablets in quantities of 60 units. This competitively awarded, firm fixed-price contract includes performance through September 11, 2025, with the place of performance located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. The contract carries no set-aside designation, reflecting the contractor's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Risperdal 3 mg tablets in quantities of 60 units, with a ceiling value of $6,678.85 and a firm fixed-price structure. This non-set-aside competitive award is scheduled for completion by September 17, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Risperdal 0.5 mg tablets (60-count packages) with a contract value of $1,130.40. This is a firm fixed-price delivery order with an ultimate completion date of July 24, 2025, with performance to be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award was competitively awarded with no set-aside designation and represents a child...
- The Defense Logistics Agency awarded a delivery order valued at $7,581.86 to AmerisourceBergen Drug Corp for the supply of Risperdal 2 mg tablets (60-count units). This firm fixed-price, non-set-aside contract was awarded on September 8, 2025, with an ultimate completion date of September 9, 2025. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order represents a child contract executed under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $1,387.02 delivery order to AmerisourceBergen Drug Corp for 60 tablets of Risperdal 2 mg, a pharmaceutical product used in treating psychiatric conditions. This firm fixed-price delivery order, awarded on August 20, 2025, with an ultimate completion date of August 21, 2025, is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract utilizes no set-aside designation, indicating it was competitively awarded...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,046.40 to AmerisourceBergen Drug Corp for the supply of Risperdal 0.5 mg tablets (60-count units) on September 15, 2025, with an ultimate completion date of September 16, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child order under...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of Risperdal 0.5 mg tablets (60 count) with a ceiling value of $3,787.60. This competitively awarded, firm fixed-price delivery order is set to be completed by August 7, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract represents a single delivery order under AmerisourceBergen's larger pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Risperdal (risperidone) 2 mg tablets in a 60-count configuration, valued at $1,396.10. This non-set-aside contract was competitively awarded on April 1, 2025, with an ultimate completion date of April 2, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract utilizes firm fixed price terms under a delivery order structure. This...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $3,202.26 by the Defense Logistics Agency on August 15, 2025, for the supply of Risperdal 2 mg tablets (60-count packaging). This firm fixed-price, non-set-aside contract has an ultimate completion date of August 18, 2025, and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The delivery will be performed at...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 12, 2025, for the supply of Risperdal 0.5 mg tablets (60-count packages) with a ceiling value of $3,722.17. This competitively awarded, firm fixed-price delivery order is not set-aside and will be completed by June 13, 2025. The place of performance is the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's broader...
- SPE2DB20D2014Indefinite Delivery Contract
- SPE2DB20D2014-SPE2DB25FC89FDelivery Order
The Defense Logistics Agency awarded a $2,523.74 delivery order to AmerisourceBergen Drug Corp for 60 tablets of Risperdal 0.5 mg on September 3, 2025, with completion targeted for September 4, 2025. The contract, which carries no set-aside designation, was competitively awarded on a firm fixed-price basis. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and will perform work at its corporate office location in the same municipality. This delivery order represents a task issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999,999,999 vehicle that extends through December 2026. The broader IDC establishes AmerisourceBergen as a pharmaceutical prime vendor for global military healthcare support, enabling the supply of a comprehensive range of medications, vaccines, and medical supplies across multiple therapeutic domains to the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems worldwide. Risperdal, an atypical antipsychotic medication, falls within the neurological and psychiatric treatment portfolio that AmerisourceBergen routinely supplies through its federal medical procurement contracts.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.5k | 9/3/25 |